Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

As of late, it has definitely been a great time to be an investor in Select Medical.

Will Select Medical Continue to Surge Higher?

Select Medical Holdings Corp (SEM) CFO Robert Ortenzio on Q4 2019 Results - Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of 55.00% and 2.80%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q4 Earnings and Revenues Top Estimates

Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.

What's in Store for Select Medical's (SEM) Q4 Earnings?

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Reports Next Week: What You Should Expect

Select Medical saw its IBD SmartSelect Composite Rating rise to 97 Monday, up from 94 the day before. 
The post Select Medical Receives IBD Stock Rating Upgrade appeared first on Investor's Business Daily.

Select Medical Receives IBD Stock Rating Upgrade

Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.

Will Select Medical's Solid Run in 2019 Sustain in 2020?

In the latest trading session, Select Medical (SEM) closed at $23.10, marking a -0.17% move from the previous day.

Select Medical (SEM) Stock Moves -0.17%: What You Should Know

Installed Building Products

Meritage Homes

Insight Enterprises

Universal Forest Products

The U.S. economy is in good shape with a robust labor market, higher consumer spending and a dovish monetary stance taken by the Fed.

5 Must-Buy Top-Ranked Mid-Cap Stocks for 2020

TopBuild

Comfort Systems USA

Courtesy of positive seasonal trend, the passage of the USMCA trade deal to replace NAFTA, US-China trade truce and improving economic data, we are lined up for a strong year-end rally.

Real Santa Rally Comes After Christmas: 5 Solid Buys

Amedisys

DaVita

LHC Group

Increasing incidence of chronic diseases, aging U.S. population, innovation and consolidation will drive the healthcare industry's growth in 2020.

5 Healthcare Stocks to Keep the Winning Streak Alive in 2020

Molina Healthcare

WellCare Health Plans

Anthem

HMO Industry Outlook: Multiple Levers to Drive Growth

Bull Of The Day: Select Medical Holdings (SEM)

Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.

Here's Why Select Medical (SEM) Stock Looks Attractive

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

Global X Genomics & Biotechnology ETF

iShares U.S. Healthcare Providers ETF

Ironwood Pharma

Jounce Therapeutics

Osmotica Pharmaceuticals Plc

ALPS Medical Breakthroughs ETF

Healthcare bounced back with an outperformance starting the fourth quarter.

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

FTI Consulting

Huron Consulting Group

McGrath RentCorp

Tenet Healthcare

The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite lingering trade conflict and global economic slowdown.

ISM Services Index Rebounds in October: 5 Top-Ranked Picks

Select Medical Holdings Corp (SEM) on Q3 2019 Results - Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of 50.00% and 4.64%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Surpasses Q3 Earnings and Revenue Estimates

Select Medical Holdings Corp (SEM) on Q2 2019 Results - Earnings Call Transcript

Select Medical Holdings' (SEM) Management on Q1 2019 Results - Earnings Call Transcript

News for Select Medical Holdings Stock (SEM)